Upexi, Inc. Notified of Nasdaq Minimum Bid Price Non-Compliance

What Happened

• Upexi, Inc. announced in an 8‑K that on July 30, 2026 it received a Nasdaq notice that its common stock had failed to meet the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). Nasdaq determined the stock’s closing bid was below $1.00 for 30 consecutive business days from June 16, 2026 through July 29, 2026.

Key Details

• Nasdaq initial compliance period: 180 calendar days, expiring January 26, 2027.
• To regain compliance: closing bid must be at least $1.00 for a minimum of 10 consecutive business days (Nasdaq may require a longer period).
• Reverse stock split option: if used, it must be completed no later than 10 business days before the compliance-period expiration.
• If not regained by January 26, 2027, the company may be eligible for an additional 180‑day period only if it meets other Nasdaq listing requirements and provides written notice of its intent to cure the deficiency.

Why It Matters

• The notice does not trigger immediate delisting, but failure to cure the deficiency could ultimately lead to delisting or placement on a different trading tier—events that can reduce liquidity and marketability of the shares. Upexi stated it will monitor the closing bid price and evaluate alternatives, including a reverse stock split, but noted there is no assurance it will regain compliance within the compliance period. Investors should watch the company’s stock price and any corporate actions or updates from Upexi regarding steps to regain compliance.